Breaking News, Financial News

Financial Report: WuXi PharmaTech

Revenues climb 22% in 2011

WuXi PharmaTech

4Q Revenues: $108.5 million (+23%)

4Q Earnings: $23.5 million (+36%)

FY Revenues: $407.2 million (+22%)

FY Earnings: $81.0 million (+11%)

Comments: In the quarter manufacturing revenues were $15.7 million (+56%) and for year were $75.2 million (+92%). Laboratory services revenue was $92.8 million in the quarter (+18%) and $332.0 million for the year (+13%). China-based lab services accounted for $72.0 million in the quarter, up 21%, and $251.7 million for the year, up 15%. U.S. lab services increased 10% in the quarter to $20.8 million, and increased 6% for the year to $80.3 million.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters